Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2018

Apr 3, 2018

29875_dirs_2018-04-03_ae575dd8-9267-4b8b-9902-dae6166bd256.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2018-04-01

Reporting Person: Denton David M (EVP and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-04-01 Common Stock F 4351 $62.21 Disposed 25494.99 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-04-01 Stock Option $62.21 A 116767 Acquired 2025-04-01 Common Stock (116767) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (restricted) 104447 Direct
ESOP Common Stock 1734.9293 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $74.29 2021-04-01 Common Stock (32618) 32618 Direct
Stock Option $102.26 2022-04-01 Common Stock (34382) 34382 Direct
Stock Option $104.82 2023-04-01 Common Stock (48980) 48980 Direct
Stock Option $78.05 2024-04-03 Common Stock (89310) 89310 Direct

Footnotes

F1: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan.

F2: Option becomes exercisable in four equal annual installments, commencing 4/1/2019.

F3: Option became exercisable in four equal annual installments, commencing 4/1/2015.

F4: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F5: Option became exercisable in four equal annual installments, commencing 4/1/2017.

F6: Option became exercisable in four equal annual installments, commencing 4/3/2018.